News headlines about Invuity (NASDAQ:IVTY) have trended somewhat positive on Saturday, Accern Sentiment Analysis reports. The research firm identifies positive and negative news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Invuity earned a media sentiment score of 0.00 on Accern’s scale. Accern also gave media stories about the medical instruments supplier an impact score of 47.5836026883392 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
Invuity (NASDAQ:IVTY) traded up 3.33% during trading on Friday, reaching $6.20. 192,613 shares of the company’s stock traded hands. Invuity has a one year low of $4.50 and a one year high of $14.25. The firm’s market capitalization is $105.71 million. The company has a 50-day moving average price of $7.28 and a 200 day moving average price of $7.59.
Invuity (NASDAQ:IVTY) last announced its earnings results on Tuesday, July 25th. The medical instruments supplier reported ($0.61) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.54) by $0.07. Invuity had a negative return on equity of 140.69% and a negative net margin of 114.61%. The business had revenue of $9.77 million for the quarter, compared to analyst estimates of $10.30 million. On average, analysts anticipate that Invuity will post ($2.38) earnings per share for the current fiscal year.
IVTY has been the subject of a number of research reports. Northland Securities restated an “outperform” rating and set a $13.00 target price on shares of Invuity in a research report on Sunday, April 23rd. Stifel Nicolaus restated a “buy” rating and set a $10.00 target price (up previously from $9.00) on shares of Invuity in a research report on Thursday, April 27th. Zacks Investment Research lowered shares of Invuity from a “hold” rating to a “sell” rating in a research report on Monday, May 1st. Finally, William Blair restated a “buy” rating on shares of Invuity in a research report on Tuesday, May 23rd. One analyst has rated the stock with a sell rating and six have assigned a buy rating to the company’s stock. Invuity currently has an average rating of “Buy” and a consensus target price of $15.17.
In other news, Director Eric W. Roberts purchased 5,000 shares of the stock in a transaction dated Monday, May 15th. The shares were purchased at an average price of $7.88 per share, with a total value of $39,400.00. Following the transaction, the director now owns 101,529 shares in the company, valued at approximately $800,048.52. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Eric W. Roberts purchased 6,500 shares of the stock in a transaction dated Thursday, May 18th. The shares were purchased at an average cost of $7.07 per share, for a total transaction of $45,955.00. Following the transaction, the director now owns 106,029 shares in the company, valued at approximately $749,625.03. The disclosure for this purchase can be found here. Insiders own 10.50% of the company’s stock.
Receive News & Ratings for Invuity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invuity Inc. and related companies with our FREE daily email newsletter.